{"docid":"VWS-WOO-08-948835","collapsed":true,"count":2,"unchecked":0,"snapshots_total":7,"versions":[{"archive_id":"folder_import_573_78fee88716da4b150f1c868926a9bccb","bestandsnaam":"VWS-WOO-08-948835.pdf","created_date":"2025-09-08 18:22:03","last_seen":"2025-09-08 18:22:03","from_file":"folder_import","bron":"/volume3/websites/openrijksoverheid/documenten_files/VWS-WOO-08-948835.pdf","snippet":"Informatie werkgroep Indicatiestelling enprioritering hyperimmuun COVID-19 immuunglobuline: Leden enOpdracht\nBijgewerkt d.d. 11-9-2020\nLeden:\nOpdracht Werkgroep indicatiestellingenprioritering anti-CO","digest":"1b8478ba30ab","dupes":6,"date_to":"2025-09-08 18:22:03","date_from":"2025-02-18 12:18:13","unchecked":false},{"archive_id":"43051","bestandsnaam":"VWS-WOO-08-948835-Informatie_werkgroep_Indicatiestelling_en_prioritering_hyperimmuunCOVID....docx.pdf","created_date":"2025-02-18 12:18:03","last_seen":"2025-02-18 12:18:03","from_file":"Besluit__dossier_nr_-14463f095e9ec956e456d616d78134ed0ddfad1e2cf89cd8bd19f80bc5928102.zip","bron":"Z:\\ARCHIEF WOO Documenten\\archieven_files\\Besluit__dossier_nr_-14463f095e9ec956e456d616d78134ed0ddfad1e2cf89cd8bd19f80bc5928102.zip","snippet":"Besluiten\nSpreadsheet ishet nul scenario >gereed 15december >\nEigen systeem exporteert degegevens naar een bestand dat wordt verzonden aan het RIVM\nToewerken naar nood bronsysteem met mobiel invoer pr","digest":"n/a","dupes":1,"date_to":"2025-02-18 12:18:03","date_from":"2025-02-18 12:18:03","unchecked":false}],"raw":[{"archive_id":"folder_import_573_78fee88716da4b150f1c868926a9bccb","bestandsnaam":"VWS-WOO-08-948835.pdf","created_date":"2025-09-08 18:22:03","last_seen":"2025-09-08 18:22:03","from_file":"folder_import","bron":"/volume3/websites/openrijksoverheid/documenten_files/VWS-WOO-08-948835.pdf","snippet":"Informatie werkgroep Indicatiestelling enprioritering hyperimmuun COVID-19 immuunglobuline: Leden enOpdracht\nBijgewerkt d.d. 11-9-2020\nLeden:\nOpdracht Werkgroep indicatiestellingenprioritering anti-CO","digest":"1b8478ba30ab"},{"archive_id":"VWS-WOO-3405320-1033219-PDO-1f026c98-54a2-616e-b0bd-65673e0af118.zip_752","bestandsnaam":"VWS-WOO-08-948835.pdf","created_date":"2025-09-04 16:59:32","last_seen":"2025-09-04 16:59:32","from_file":"VWS-WOO-3405320-1033219-PDO-1f026c98-54a2-616e-b0bd-65673e0af118.zip","bron":"../../archieven_files/VWS-WOO-3405320-1033219-PDO-1f026c98-54a2-616e-b0bd-65673e0af118.zip","snippet":"Informatie werkgroep Indicatiestelling enprioritering hyperimmuun COVID-19 immuunglobuline: Leden enOpdracht\nBijgewerkt d.d. 11-9-2020\nLeden:\nOpdracht Werkgroep indicatiestellingenprioritering anti-CO","digest":"1b8478ba30ab"},{"archive_id":"VWS-WOO-3405320-1033219-PDO-1f03af74-9059-6598-b46a-e1433ef450d1.zip_790","bestandsnaam":"VWS-WOO-08-948835.pdf","created_date":"2025-09-04 16:37:56","last_seen":"2025-09-04 16:37:56","from_file":"VWS-WOO-3405320-1033219-PDO-1f03af74-9059-6598-b46a-e1433ef450d1.zip","bron":"../../archieven_files/VWS-WOO-3405320-1033219-PDO-1f03af74-9059-6598-b46a-e1433ef450d1.zip","snippet":"Informatie werkgroep Indicatiestelling enprioritering hyperimmuun COVID-19 immuunglobuline: Leden enOpdracht\nBijgewerkt d.d. 11-9-2020\nLeden:\nOpdracht Werkgroep indicatiestellingenprioritering anti-CO","digest":"1b8478ba30ab"},{"archive_id":"324609","bestandsnaam":"VWS-WOO-08-948835.pdf","created_date":"2025-03-18 09:30:25","last_seen":"2025-03-18 09:30:25","from_file":"2024.075-VWS-WOO-3405320-1033219-PDO.zip","bron":"Z:\\ARCHIEF WOO Documenten\\archieven_files\\2024.075-VWS-WOO-3405320-1033219-PDO.zip","snippet":"Informatie werkgroep Indicatiestelling enprioritering hyperimmuun COVID-19 immuunglobuline: Leden enOpdracht\nBijgewerkt d.d. 11-9-2020\nLeden:\nOpdracht Werkgroep indicatiestellingenprioritering anti-CO","digest":"1b8478ba30ab"},{"archive_id":"237163","bestandsnaam":"VWS-WOO-08-948835.pdf","created_date":"2025-02-27 09:25:04","last_seen":"2025-02-27 09:25:04","from_file":"2023.057-VWS-WOO-3405320-1033219-PDO.zip","bron":"Z:\\ARCHIEF WOO Documenten\\archieven_files\\2023.057-VWS-WOO-3405320-1033219-PDO.zip","snippet":"Informatie werkgroep Indicatiestelling enprioritering hyperimmuun COVID-19 immuunglobuline: Leden enOpdracht\nBijgewerkt d.d. 11-9-2020\nLeden:\nOpdracht Werkgroep indicatiestellingenprioritering anti-CO","digest":"1b8478ba30ab"},{"archive_id":"108698","bestandsnaam":"VWS-WOO-08-948835.pdf","created_date":"2025-02-18 12:18:13","last_seen":"2025-02-18 12:18:13","from_file":"VWS-WOO-3405320-1033219-PDO-14463f095e9ec956e456d616d78134ed0ddfad1e2cf89cd8bd19f80bc5928102.zip","bron":"Z:\\ARCHIEF WOO Documenten\\archieven_files\\VWS-WOO-3405320-1033219-PDO-14463f095e9ec956e456d616d78134ed0ddfad1e2cf89cd8bd19f80bc5928102.zip","snippet":"Informatie werkgroep Indicatiestelling enprioritering hyperimmuun COVID-19 immuunglobuline: Leden enOpdracht\nBijgewerkt d.d. 11-9-2020\nLeden:\nOpdracht Werkgroep indicatiestellingenprioritering anti-CO","digest":"1b8478ba30ab"},{"archive_id":"43051","bestandsnaam":"VWS-WOO-08-948835-Informatie_werkgroep_Indicatiestelling_en_prioritering_hyperimmuunCOVID....docx.pdf","created_date":"2025-02-18 12:18:03","last_seen":"2025-02-18 12:18:03","from_file":"Besluit__dossier_nr_-14463f095e9ec956e456d616d78134ed0ddfad1e2cf89cd8bd19f80bc5928102.zip","bron":"Z:\\ARCHIEF WOO Documenten\\archieven_files\\Besluit__dossier_nr_-14463f095e9ec956e456d616d78134ed0ddfad1e2cf89cd8bd19f80bc5928102.zip","snippet":"Besluiten\nSpreadsheet ishet nul scenario >gereed 15december >\nEigen systeem exporteert degegevens naar een bestand dat wordt verzonden aan het RIVM\nToewerken naar nood bronsysteem met mobiel invoer pr","digest":"n/a"}],"filename":"Informatie werkgroep Indicatiestelling en prioritering hyperimmuunCOVID....docx","truncated":false,"elapsed_ms":1}